基于妊娠11-13周生物物理与生物化学标志物的竞争风险模型预测小于胎龄儿
这项前瞻性观察研究纳入60 875例单胎妊娠孕妇,在11+0至13+6周测量PAPP-A、PlGF、UtA-PI和MAP,利用竞争风险模型结合母体因素与生物标志物预测小于胎龄儿。联合全部标志物在10%假阳性率下对分娩≥37周、<37周和<32周的出生体重<第10百分位SGA分别预测34.3%、48.6%和59.1%,模型校准良好。
要点
- 早孕期UtA-PI是早产SGA的最佳生物物理预测指标,PlGF是最佳生物化学标志物。
- 联合母体因素与全部标志物在10%假阳性率下预测出生体重<第10百分位SGA:≥37周34.3%、<37周48.6%、<32周59.1%。
- 预测性能随早产程度增加、SGA严重程度增加、合并子痫前期及标志物数量增加而提高。
核心结论
- 研究提出一个连续二维模型,可针对任意SGA严重程度切点与分娩孕周切点预测SGA,为个体化产前预测与管理方案奠定基础。
- 联合母体因素与全部标志物在10%假阳性率下预测出生体重<第10百分位SGA:分娩≥37周34.3%、<37周48.6%、<32周59.1%。
- 对应出生体重<第3百分位分别为39.9%、53.2%和64.4%,合并子痫前期时分别为46.3%、66.8%和80.4%。
研究设计与样本
- 前瞻性观察研究,纳入60 875例单胎妊娠孕妇,于11+0至13+6周行常规超声检查。
- 全部妊娠测量妊娠相关血浆蛋白A与胎盘生长因子,59 001例测量子宫动脉搏动指数,58 479例测量平均动脉压,57 131例具备全部标志物完整数据。
- 采用既往开发的竞争风险模型描述分娩孕周与出生体重Z评分的联合分布,生物物理标志物似然度通过折叠平面回归模型拟合。
- 依据贝叶斯定理以似然度修正先验分布,获得分娩孕周与出生体重Z评分的个体化分布,并用57 131例完整数据评估模型判别力与校准度。
诊断标准与关键数值
- 早产SGA的最佳生物物理预测指标为UtA-PI,最佳生物化学标志物为PlGF。
- 联合母体因素与全部标志物在10%假阳性率下预测出生体重<第10百分位SGA:≥37周34.3%、<37周48.6%、<32周59.1%。
- 出生体重<第3百分位SGA对应值分别为39.9%、53.2%和64.4%。
- 出生体重<第3百分位合并子痫前期对应值分别为46.3%、66.8%和80.4%。
- 模型校准良好,预测性能随早产程度、SGA严重程度、合并子痫前期及标志物数量增加而提高。
临床应用与阅片要点
- 该连续二维模型允许使用者自定义SGA严重程度与分娩孕周切点,用于个体化产前预测。
- 早孕期联合母体因素、UtA-PI、MAP、PAPP-A与PlGF可对SGA进行风险分层,早产程度越高、SGA越重预测性能越好。
- 作者认为该模型为在新倒金字塔产前保健模式下预测和管理SGA的个体化产前方案奠定基础。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a new competing-risks model for the prediction of a small-for-gestational-age (SGA) neonate, based on maternal factors and biophysical and biochemical markers at 11-13 weeks' gestation.
METHODS: This was a prospective observational study in 60 875 women with singleton pregnancy undergoing routine ultrasound examination at 11 + 0 to 13 + 6 weeks' gestation. All pregnancies had pregnancy-associated plasma protein-A and placental growth factor (PlGF) measurements, 59 001 had uterine artery pulsatility index (UtA-PI) measurements and 58 479 had mean arterial pressure measurements; 57 131 cases had complete data for all biomarkers. We used a previously developed competing-risks model for the joint distribution of gestational age (GA) at delivery and birth-weight Z-score, according to maternal demographic characteristics and medical history. The likelihoods of the biophysical markers were developed by fitting folded-plane regression models, a technique that has already been used in previous studies for the likelihoods of biochemical markers. The next step was to modify the prior distribution by the likelihood, according to Bayes' theorem, to obtain individualized distributions for GA at delivery and birth-weight Z-score. We used the 57 131 cases with complete data to assess the discrimination and calibration of the model for predicting SGA with, without or independently of pre-eclampsia, by different combinations of maternal factors and biomarkers.
RESULTS: The distribution of biomarkers, conditional to both GA at delivery and birth-weight Z-score, was best described by folded-plane regression models. These continuous two-dimensional likelihoods update the joint distribution of birth-weight Z-score and GA at delivery that has resulted from a competing-risks approach; this method allows application of user-defined cut-offs. The best biophysical predictor of preterm SGA was UtA-PI and the best biochemical marker was PlGF. The prediction of SGA was consistently better for increasing degree of prematurity, greater severity of smallness, coexistence of PE and increasing number of biomarkers. The combination of maternal factors with all biomarkers predicted 34.3%, 48.6% and 59.1% of all cases of a SGA neonate with birth weight < 10th percentile delivered at ≥ 37, < 37 and < 32 weeks' gestation, at a 10% false-positive rate. The respective values for birth weight < 3rd percentile were 39.9%, 53.2% and 64.4%, and for birth weight < 3rd percentile with pre-eclampsia they were 46.3%, 66.8% and 80.4%. The new model was well calibrated.
CONCLUSIONS: This study has presented a single continuous two-dimensional model for prediction of SGA for any desired cut-offs of smallness and GA at delivery, laying the ground for a personalized antenatal plan for predicting and managing SGA, in the milieu of a new inverted pyramid of prenatal care. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Papastefanou I, Wright D, Syngelaki A, et al. Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2020. PMID: 33094535. doi:10.1002/uog.23523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。